ニュース
16 時間on MSN
In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.
Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to ...
Losing weight after a years-long struggle, this letter writer gave credit to the method — then came the judgmental comments.
15 時間
Verywell Health on MSN8 Teas to Help You Lose Weight and Reduce Belly FatGreen tea is one of the best teas for weight loss because it helps oxidize fat. Learn how green tea and others support weight ...
The millions of people living with obesity need novel treatment options that are safe, effective and avoid the high costs and ...
Polycystic ovary syndrome (PCOS) is a complex hormonal condition affecting an estimated eight to 20 percent of women of ...
Pedersen and Stine Jacobsen COPENHAGEN (Reuters) - Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday ...
4 時間on MSN
Newer medications, such as Mounjaro and Wegovy, exhibit both more total weight lost and faster weight regain than older ...
Researchers also found that about one-third of teens undergoing weight-loss surgery had a body mass index (BMI) of more than ...
Former FDA Commissioner David Kessler shared his experience with GLP-1 weight loss drugs on "CBS Mornings Plus." ...
18 時間on MSN
Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down ...
Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する